Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
James Januzzi, MD
The effect of icosapent ethyl on CV events in metabolic syndrome
Michael Miller, MD
Antoni Bayés-Genís, MD, PhD
Patrick Rossignol, MD, PhD
Amy Groenewegen, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.